Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/16/1998 | WO1998023752A3 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses |
07/16/1998 | WO1998022496A3 Antiviral peptide derivatives |
07/16/1998 | WO1998021222A3 1-galactose derivatives |
07/16/1998 | WO1998021213A3 2R,4S,R,S- and 2S,4R,R,S-hydroxyitraconazole- and hydroxysaperconazole derivatives |
07/16/1998 | CA2278326A1 Eukaryotic gene expression cassette and uses thereof |
07/16/1998 | CA2278158A1 Cytokine related treatments of disease |
07/16/1998 | CA2277910A1 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
07/16/1998 | CA2277116A1 Tricyclic erythromycin derivatives |
07/16/1998 | CA2276525A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
07/16/1998 | CA2276085A1 Secreted proteins and polynucleotides encoding them |
07/16/1998 | CA2276046A1 Novel epithelial tissue targeting agent |
07/16/1998 | CA2275659A1 Photochemotherapeutic compositions |
07/16/1998 | CA2274731A1 Myelopeptides and their therapeutic use |
07/15/1998 | EP0853125A2 cDNA clone HNFJD15 that encodes a human 7-transmembrane receptor |
07/15/1998 | EP0853083A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof |
07/15/1998 | EP0852950A1 Nitrogen monoxide production suppressor |
07/15/1998 | EP0852948A1 Use of glycosidase inhibitor for the preparation of a medicament for the prophylaxis or treatment of malaria, endotoxic shock or septic shock |
07/15/1998 | EP0852624A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
07/15/1998 | EP0852618A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
07/15/1998 | EP0852586A1 Binding protein |
07/15/1998 | EP0852502A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
07/15/1998 | EP0852500A1 Modified ether glyceroglycolipids |
07/15/1998 | EP0852497A1 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections |
07/15/1998 | EP0642355B1 Combined vaccines comprising hepatitis b surface antigen and other antigens |
07/15/1998 | EP0509019B1 Treatment of human retroviral infections with 2',3'-dideoxyinosine |
07/15/1998 | CN1187821A Rapamycin derivatives |
07/15/1998 | CN1187369A Nitrogen oxide generation inhibitor |
07/14/1998 | US5780605 6,9-bridged erythromycin derivatives |
07/14/1998 | US5780604 Bactericides |
07/14/1998 | US5780601 Method for purification of protein "e" from haemophilus influenzae |
07/14/1998 | US5780516 Material and methods for inhibiting bacterial cell wall biosynthesis |
07/14/1998 | US5780508 Pharmacological preparations comprising a cystine derivative |
07/14/1998 | US5780462 Methoxypoly(ethylene glycol) esters of rapamycin |
07/14/1998 | US5780454 Boronic ester and acid compounds |
07/14/1998 | US5780448 Administering expression vector |
07/14/1998 | US5780287 Photoactivated antiviral and antitumor compositions |
07/14/1998 | US5780278 Nucleic acid encoding ?induced by contact with epithelium? (ice) protein of helicobacter pylori; diagnosis of gastrointestinal disorders |
07/14/1998 | US5780080 Cabbages treated to control post-harvest diseases |
07/14/1998 | US5780064 Germicidal compositions for the treatment of animal infectious diseases of the hoof |
07/14/1998 | US5780040 Helicobacter pylori nickel binding protein |
07/14/1998 | US5780037 Determining the relative concentration of calcium-dependent sugar-binding proteins in an aqueous extract with respect to the total protein concentration to identify pharmaceutical grade products; aids; anticarcinogenic agents |
07/14/1998 | US5780036 Peptides for inducing cytotoxic T lymphocyte responses to hepattis B virus |
07/14/1998 | CA2131372C Sugar derivatives of macrolides |
07/14/1998 | CA1339954C Dogs - and horse - interferones |
07/14/1998 | CA1339953C 2',5'-phosphorothioate oligoadenylates and antiviral uses thereof |
07/09/1998 | WO1998029452A1 Antibodies specifically recognising a nitrosylated protein, method of preparation, therapeutic and diagnostic use |
07/09/1998 | WO1998029444A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
07/09/1998 | WO1998029442A1 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
07/09/1998 | WO1998029435A1 Peptidomimetic inhibitors of the human cytomegalovirus protease |
07/09/1998 | WO1998029432A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
07/09/1998 | WO1998029417A1 Cyclic organoselenium compounds, their preparation and their uses |
07/09/1998 | WO1998029416A1 Cephem compounds |
07/09/1998 | WO1998029395A1 Process for producing imidazole derivatives |
07/09/1998 | WO1998029121A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
07/09/1998 | WO1998029119A1 Inhibitors of farnesyl-protein transferase |
07/09/1998 | WO1998029101A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
07/09/1998 | WO1998020836A3 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections |
07/09/1998 | WO1998008542A3 Compounds and methods for treatment and diagnosis of mycobacterial infections |
07/09/1998 | WO1998007745A3 Compositions and methods for treating infections using analogues of indolicidin |
07/09/1998 | CA2650204A1 Pharmaceutical preparations of glutathione and methods of administration thereof |
07/09/1998 | CA2276745A1 Mycobacterium fol a gene that encodes for the enzyme dihydrofolate reductase |
07/09/1998 | CA2276450A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
07/09/1998 | CA2276150A1 Inhibitors of farnesyl-protein transferase |
07/09/1998 | CA2276112A1 Broad spectrum pyrogenic exotoxins antagonists and vaccines |
07/09/1998 | CA2276097A1 Cephem compounds |
07/09/1998 | CA2274909A1 Cyclic organoselenium compounds, their preparation and their uses |
07/09/1998 | CA2274585A1 Annexin v-binding polypeptides derived from hbsag and their uses |
07/08/1998 | EP0852231A2 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesis intermediate thereof and process for producing the same |
07/08/1998 | EP0851927A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
07/08/1998 | EP0851875A2 Dna sequences and secreted proteins encoded thereby |
07/08/1998 | EP0851873A2 Parainfluenza virus glycoproteins and vaccines |
07/08/1998 | EP0851866A1 Therapeutic compounds |
07/08/1998 | EP0851857A1 Inhibitors of tumor necrosis factor alpha |
07/08/1998 | EP0851765A1 Therapeutic and prophylactic methods using heat shock proteins |
07/08/1998 | EP0851753A1 Aerosol compositions |
07/08/1998 | EP0750611B1 Anilide derivatives as fungicides |
07/08/1998 | EP0748806B1 PROCESS FOR PREPARING POLYMORPHS B AND C OF 1- 2,4-DICHLORO-BETA-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE |
07/08/1998 | EP0571538B1 Structural gene of pneumococcal protein |
07/08/1998 | CN1187136A Modified meningococcal polysacharide conjugate vaccines |
07/08/1998 | CN1187129A Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties |
07/08/1998 | CN1186689A Medicine for curing psoriasis |
07/08/1998 | CN1186666A Azithromycin suppository and ointment |
07/08/1998 | CN1186658A Medicinal paster for external use |
07/08/1998 | CN1039014C Modified oligodeoxyribonucleotides |
07/08/1998 | CN1039012C Novel phospholipid derivatives |
07/08/1998 | CA2226478A1 Nitrogen monoxide production suppressor |
07/08/1998 | CA2210677A1 Use of glycosidase inhibitors |
07/07/1998 | US5777193 Animals with targeted gene disruption |
07/07/1998 | US5777095 Dna and nucleotide sequences |
07/07/1998 | US5777083 Stress protein epitopes |
07/07/1998 | US5777074 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
07/07/1998 | US5776974 Immunosuppressant compounds |
07/07/1998 | US5776966 Selective cell inactivation in blood |
07/07/1998 | US5776947 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumor necrosis factor (TNF) and/or for the treatment of septic shock |
07/07/1998 | US5776943 Rapamycin metabolites |
07/07/1998 | US5776933 Method of inhibiting protease |
07/07/1998 | US5776926 Cefixime composition |
07/07/1998 | US5776919 Potentiators of antimicrobial activity |
07/07/1998 | US5776912 Lipophilic oligosaccharide antibiotic compositions |
07/07/1998 | US5776910 Dna molecule codes and fc receptors |